Pacemaker lead-related tricuspid stenosis successfully treated with percutaneous balloon valvuloplasty guided by 3D echocardiography
Juan Carlos Rama-Merchan, Antonio Arribas-Jimenez, Javier Martin-Moreiras and 2 more
Revista Portuguesa de Cardiologia · 2014
doi:10.1016/j.repc.2014.06.006 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The most common etiology of tricuspid stenosis is rheumatic, and in most cases it is associated with valvular regurgitation. Interestingly, there have been reports of tricuspid stenosis without associated valvular regurgitation, mostly related to pacemaker leads. Percutaneous tricuspid valvuloplasty may be a therapeutic alternative to surgery in cases of pure tricuspid stenosis without other concomitant valvulopathies. We report the case of a 52-year-old woman with pacemaker lead-related tricuspid stenosis successfully treated with percutaneous valvuloplasty guided by 3D echocardiography. Resumo: A causa mais comum da estenose tricúspide é reumática, e na maioria dos casos está associada com insuficiência valvular. Curiosamente, tem havido relatos de estenose tricúspide sem insuficiência associada, sendo a maioria associados com electrocateteres de pacemaker. A plastia da valva tricúspide pode ser uma alternativa em casos de estenose valvular tricúspide pura, sem outras valvulopatias concomitantes. Relatamos o caso de uma mulher de 52 anos com estenose tricúspide associada a electrocateter de pacemaker tratada com sucesso com valvuloplastia percutânea guiada por ecocardiografia 3D. Keywords: Tricuspid stenosis, Pacemaker, Balloon valvuloplasty, 3D echocardiography, Palavras-chave: Estenose tricúspide, Pacemaker, Valvuloplastia com balão, Ecocardiografia 3D
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.